News AstraZeneca PLC Xetra

Stocks

ZEG

GB0009895292

Pharmaceuticals

Delayed Xetra 11:35:36 2026-02-05 EST			5-day change	1st Jan Change
160.70 ^EUR	+0.59%		-.--%	+1.81%

09-18	Alexion Biologics License Application for Efzimfotase Alfa Accepted and Granted Priority Review by Us Fda for Treatment of Patients with Hypophosphatasia Aged 2 Years and Older	CI
09-18	European Stocks Close Sharply Lower in Friday Trading as Middle East Fighting Continues to Choke Oil Supply	MT

All News

Mentions Relevance

09-18	Alexion Biologics License Application for Efzimfotase Alfa Accepted and Granted Priority Review by Us Fda for Treatment of Patients with Hypophosphatasia Aged 2 Years and Older	CI
09-18	AstraZeneca drug Klygefa gains positive opinion from EU's CHMP	AN
09-18	AstraZeneca's Alexion Gets Positive EU Recommendation for Klygefa in Rare Muscle Disease	MT
09-18	EU Medicines Agency Panel Backs Indication Extension for AstraZeneca, Daiichi Sankyo's Breast Cancer Drug	MT
09-18	AstraZeneca : Klygefa (gefurulimab) recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis (gMG)	PU
09-18	AstraZeneca, Daiichi celebrate another recommended approval of Enhertu	AN
09-18	AstraZeneca, Daiichi Sankyo's Enhertu Recommended for EU Approval for HER2 Positive Breast Cancer	MT
09-18	AstraZeneca's Alexion Wins European Medicines Agency Panel's Positive Opinion for Autoimmune Disease Drug	MT
09-18	AstraZeneca chief executive buys GBP7 million in shares	AN
09-18	Big Picture Bio Founded to Identify, Design and Optimise Promising Cancer Combination Therapies	AQ
09-18	Onco360(R) Has Been Selected as a National Pharmacy Partner for ETCAMAH (camizestrant)	AQ
09-18	FDA Grants Priority Review to AstraZeneca's Efzimfotase
09-18	AstraZeneca Wins FDA Priority Review for Rare Bone Disease Drug	MT
09-18	AstraZeneca hails US priority review designation for efzimfotase alfa	AN
09-18	AstraZeneca Wins US FDA Priority Review for Hypophosphatasia Therapy	MT
09-17	FTSE 100 gains after BoE holds rates steady, pauses gilt sales	RE
09-17	AstraZeneca's Enhertu Breast Cancer Drug Gets UK Recommendation	MT
09-17	AstraZeneca, Daiichi Breast-Cancer Drug Gets Nod in England After U.S. Pharma Deal	DJ
09-16	AstraZeneca, Daiichi Sankyo Secure NICE Recommendation for Enhertu as Breast Cancer Treatment	MT
09-16	AstraZeneca PLC : Gets a Buy rating from UBS	ZD
09-16	AstraZeneca PLC : Buy rating from Jefferies	ZD
09-16	AstraZeneca PLC : JP Morgan keeps its Buy rating	ZD
09-15	Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says	MT
09-15	AstraZeneca Chair Demare acquires 2,500 shares	AN
09-15	Deutsche Bank Upgrades AstraZeneca to Hold, Lifts PT	MT